ALLISON LOWIE: Open Payments
NPI 1972747699 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 51 payments from 11 companies in 2025. Trend: 2023 $1,594 · 2024 $1,694 · 2025 $1,250
Food & beverage: $1,183Education: $67
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $292 |
| Novartis Pharmaceuticals Corporation | 8 | $213 |
| UCB, Inc. | 6 | $144 |
| ABBVIE INC. | 10 | $140 |
| Galderma Laboratories, L.P. | 1 | $118 |
| Amgen Inc. | 5 | $101 |
| GENZYME CORPORATION | 3 | $98 |
| Lilly USA, LLC | 2 | $54 |
| LEO Pharma Inc. | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
Products named: TREMFYA, COSENTYX, Bimzelx, SKYRIZI, DUPIXENT, NEMLUVIO, OTEZLA, TALTZ.
Industry payments across FL — which companies pay providers there.
